Advances in Structural Intervention – SOLACI-SOCIME 2022

✔️ Advances in Structural Intervention – SOLACI-SOCIME 2022.

✔️ SOLACI-SOCIME 2022 Scientific Session

👨‍🏫 Content:

00:09 – Palabras de Bienvenida – Dr. Guering Eid-Lidt (MEX)
01:53 – Neo-commisural alignment and coronary overlap after TAVI – Dr. Luis Nombela Franco (ESP)
19:17 – Heavily calcified aortic annulus and TAVR – Dr. José Mangione (BRA)
36:15 – TAVI in cardiogenic shock – Dr. Jhonathan Uribe (MEX)
53:56 – Q&A


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Endovascular Treatment of Femoropopliteal Segment – SOLACI-SOCIME 2022

✔️ Endovascular Treatment of Femoropopliteal Segment - SOLACI-SOCIME 2022. ✔️ SOLACI-SOCIME 2022 Scientific Session 👨‍🏫 Content: 00:09 - How Palabras de bienvenida - Dr. Luis Virgen...

Pulmonary Valve – SOLACI-SOCIME 2022

✔️ Pulmonary Valve - SOLACI-SOCIME 2022 ✔️ SOLACI-SOCIME 2022 Scientific Sessions 👨‍🏫 Contents: 00:10 - How to select the type of THV in pulmonary valve...

Complex PCI: Distal Left Main Coronary Artery – SOLACI-SOCIME 2022

✔️ Complex PCI: Distal Left Main Coronary Artery - SOLACI-SOCIME 2022. ✔️ SOLACI-SOCIME 2022 Scientific Session.  👨‍🏫 Contents: 00:13 - Welcoming words - Dr. Álvaro...

CHRONIC TOTAL OCCLUSION – SOLACI-SOCIME 2022

✔️ Innovation and Advances in Cardiovascular Intervention (Sponsored by MicroPort) - SOLACI-SOCIME 2022. ✔️ SOLACI-SOCIME 2022 Scientific Session. 👨‍🏫 Content: 00:03 - Welcoming words - Dr....

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....